{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:31:56Z","timestamp":1787668316575,"version":"build-2736575974"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04788-7","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T08:09:01Z","timestamp":1740470941000},"page":"8381-8399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biology, Pathology, and Targeted Therapy of Exosomal Cargoes in Parkinson\u2019s Disease: Advances and Challenges"],"prefix":"10.1007","volume":"62","author":[{"given":"Faezeh","family":"Almasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeze","family":"Abbasloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Dehbozorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atousa","family":"Moghadam Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mesgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Zadeh Hosseingholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Payandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parjin","family":"Rahmanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"4788_CR1","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/nano11061481","volume":"11","author":"A Butreddy","year":"2021","unstructured":"Butreddy A, Kommineni N, Dudhipala N (2021) Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials 11:1481","journal-title":"Nanomaterials"},{"key":"4788_CR2","doi-asserted-by":"crossref","first-page":"136885","DOI":"10.1016\/j.chemosphere.2022.136885","volume":"310","author":"AD Khalid","year":"2023","unstructured":"Khalid AD et al (2023) Functional bioinspired nanocomposites for anticancer activity with generation of reactive oxygen species. Chemosphere 310:136885","journal-title":"Chemosphere"},{"key":"4788_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13205-023-03521-2","volume":"13","author":"S Sen","year":"2023","unstructured":"Sen S et al (2023) Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech 13:101","journal-title":"3 Biotech"},{"key":"4788_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-023-00622-7","volume":"18","author":"T Koeglsperger","year":"2023","unstructured":"Koeglsperger T et al (2023) Neuropathology of incidental Lewy body & prodromal Parkinson\u2019s disease. Mol Neurodegener 18:32","journal-title":"Mol Neurodegener"},{"key":"4788_CR5","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"A-L Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier A-L et al (2020) The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci 117:4971\u20134982","journal-title":"Proc Natl Acad Sci"},{"key":"4788_CR6","doi-asserted-by":"crossref","first-page":"129698","DOI":"10.1016\/j.molstruc.2020.129698","volume":"1231","author":"E Ghazy","year":"2021","unstructured":"Ghazy E et al (2021) Nanomaterials for Parkinson disease: recent progress. J Mol Struct 1231:129698","journal-title":"J Mol Struct"},{"key":"4788_CR7","doi-asserted-by":"crossref","first-page":"dev156117","DOI":"10.1242\/dev.156117","volume":"145","author":"M Parmar","year":"2018","unstructured":"Parmar M (2018) Towards stem cell based therapies for Parkinson\u2019s disease. Development 145:dev156117","journal-title":"Development"},{"key":"4788_CR8","doi-asserted-by":"crossref","first-page":"215531","DOI":"10.1016\/j.ccr.2023.215531","volume":"500","author":"L Qiu","year":"2024","unstructured":"Qiu L et al (2024) Micro\/nanoparticle-enabled ultrasound therapy of brain diseases. Coord Chem Rev 500:215531","journal-title":"Coord Chem Rev"},{"key":"4788_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/1535370220961788","volume":"246","author":"J Feng","year":"2021","unstructured":"Feng J (2021) Modeling the pathophysiology of Parkinson\u2019s disease in patient-specific neurons. Exp Biol Med 246:298\u2013304","journal-title":"Exp Biol Med"},{"key":"4788_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-4-1","volume":"4","author":"F Han","year":"2015","unstructured":"Han F et al (2015) Development of stem cell-based therapy for Parkinson\u2019s disease. Transl Neurodegener 4:1\u201313","journal-title":"Transl Neurodegener"},{"key":"4788_CR11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/ph15010076","volume":"15","author":"Y Ouerdane","year":"2022","unstructured":"Ouerdane Y et al (2022) Exosomes in Parkinson: revisiting their pathologic role and potential applications. Pharmaceuticals 15:76","journal-title":"Pharmaceuticals"},{"key":"4788_CR12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7150\/ijms.41515","volume":"17","author":"M Tatullo","year":"2020","unstructured":"Tatullo M et al (2020) Exosomes from human periapical cyst-MSCs: theranostic application in Parkinson\u2019s disease. Int J Med Sci 17:657","journal-title":"Int J Med Sci"},{"key":"4788_CR13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/biom10091327","volume":"10","author":"L Leggio","year":"2020","unstructured":"Leggio L et al (2020) Extracellular vesicles as nanotherapeutics for Parkinson\u2019s disease. Biomolecules 10:1327","journal-title":"Biomolecules"},{"key":"4788_CR14","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.14336\/AD.2021.0516","volume":"12","author":"R Upadhya","year":"2021","unstructured":"Upadhya R, Shetty AK (2021) Extracellular vesicles for the diagnosis and treatment of Parkinson\u2019s disease. Aging Dis 12:1438","journal-title":"Aging Dis"},{"key":"4788_CR15","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.14336\/AD.2021.0527","volume":"12","author":"L Leggio","year":"2021","unstructured":"Leggio L et al (2021) Extracellular vesicles as novel diagnostic and prognostic biomarkers for Parkinson\u2019s disease. Aging Dis 12:1494","journal-title":"Aging Dis"},{"key":"4788_CR16","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2174\/0929867328666210902142015","volume":"29","author":"Y Jiang","year":"2022","unstructured":"Jiang Y et al (2022) Engineered exosomes: a promising drug delivery strategy for brain diseases. Curr Med Chem 29:3111\u20133124","journal-title":"Curr Med Chem"},{"key":"4788_CR17","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R et al (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun 9:1305","journal-title":"Nat Commun"},{"key":"4788_CR18","first-page":"1","volume":"21","author":"Q-F Han","year":"2022","unstructured":"Han Q-F et al (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21:1\u201326","journal-title":"Mol Cancer"},{"key":"4788_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mito.2020.09.006","volume":"55","author":"X Wang","year":"2020","unstructured":"Wang X et al (2020b) Detection of mitochondria-pertinent components in exosomes. Mitochondrion 55:100\u2013110","journal-title":"Mitochondrion"},{"key":"4788_CR20","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.3390\/ijms23137408","volume":"23","author":"LD Zorova","year":"2022","unstructured":"Zorova LD et al (2022) Do extracellular vesicles derived from mesenchymal stem cells contain functional mitochondria? Int J Mol Sci 23:7408","journal-title":"Int J Mol Sci"},{"key":"4788_CR21","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.3390\/ijms22073528","volume":"22","author":"T Akoto","year":"2021","unstructured":"Akoto T, Saini S (2021) Role of exosomes in prostate cancer metastasis. Int J Mol Sci 22:3528","journal-title":"Int J Mol Sci"},{"key":"4788_CR22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3390\/cancers12071827","volume":"12","author":"GL Wong","year":"2020","unstructured":"Wong GL, Abu Jalboush S, Lo H-W (2020) Exosomal MicroRNAs and organotropism in breast cancer metastasis. Cancers 12:1827","journal-title":"Cancers"},{"key":"4788_CR23","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367. https:\/\/doi.org\/10.1126\/science.aau6977","DOI":"10.1126\/science.aau6977"},{"key":"4788_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y et al (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:19","journal-title":"Cell Biosci"},{"key":"4788_CR25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1194\/jlr.E086173","volume":"59","author":"M Record","year":"2018","unstructured":"Record M et al (2018) Extracellular vesicles: lipids as key components of their biogenesis and functions. J Lipid Res 59:1316\u20131324","journal-title":"J Lipid Res"},{"key":"4788_CR26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H et al (2023) Current strategies for exosome cargo loading and targeting delivery. Cells 12:1416","journal-title":"Cells"},{"key":"4788_CR27","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J et al (2021) The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B 11:2783\u20132797","journal-title":"Acta Pharm Sin B"},{"key":"4788_CR28","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3390\/cells10112930","volume":"10","author":"E Anakor","year":"2021","unstructured":"Anakor E et al (2021) Exosomes in ageing and motor neurone disease: biogenesis, uptake mechanisms, modifications in disease and uses in the development of biomarkers and therapeutics. Cells 10:2930","journal-title":"Cells"},{"key":"4788_CR29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/diagnostics10100843","volume":"10","author":"A Mallia","year":"2020","unstructured":"Mallia A et al (2020) Proteomics of extracellular vesicles: update on their composition, biological roles and potential use as diagnostic tools in atherosclerotic cardiovascular diseases. Diagnostics 10:843","journal-title":"Diagnostics"},{"key":"4788_CR30","doi-asserted-by":"crossref","first-page":"1263834","DOI":"10.3389\/fphar.2023.1263834","volume":"14","author":"K Ghaffari","year":"2023","unstructured":"Ghaffari K et al (2023) Application of cell-derived exosomes in the hematological malignancies therapy. Front Pharmacol 14:1263834","journal-title":"Front Pharmacol"},{"key":"4788_CR31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s13402-023-00810-z","volume":"46","author":"G Patel","year":"2023","unstructured":"Patel G et al (2023) Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer. Cell Oncol (Dordr) 46:1159\u20131179","journal-title":"Cell Oncol (Dordr)"},{"key":"4788_CR32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/ijms18030538","volume":"18","author":"M Rashed","year":"2017","unstructured":"Rashed M et al (2017) Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci 18:538","journal-title":"Int J Mol Sci"},{"key":"4788_CR33","doi-asserted-by":"crossref","first-page":"e20595","DOI":"10.1016\/j.heliyon.2023.e20595","volume":"9","author":"Q Shi","year":"2023","unstructured":"Shi Q et al (2023) The role of exosomes in the diagnosis of Parkinson\u2019s disease. Heliyon 9:e20595","journal-title":"Heliyon"},{"key":"4788_CR34","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jconrel.2022.08.002","volume":"349","author":"C Li","year":"2022","unstructured":"Li C et al (2022) Overcoming the blood-brain barrier: exosomes as theranostic nanocarriers for precision neuroimaging. J Control Release 349:902\u2013916","journal-title":"J Control Release"},{"key":"4788_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10571-024-01460-x","volume":"44","author":"Y Ge","year":"2024","unstructured":"Ge Y et al (2024) A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells. Cell Mol Neurobiol 44:24","journal-title":"Cell Mol Neurobiol"},{"key":"4788_CR36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/ijms25010255","volume":"25","author":"Y Wang","year":"2023","unstructured":"Wang Y et al (2023b) The regulation of exosome generation and function in physiological and pathological processes. Int J Mol Sci. 25:255","journal-title":"Int J Mol Sci."},{"key":"4788_CR37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.15288","volume":"157","author":"JR Pinnell","year":"2021","unstructured":"Pinnell JR, Cui M, Tieu K (2021) Exosomes in Parkinson disease. J Neurochem 157:413\u2013428","journal-title":"J Neurochem"},{"key":"4788_CR38","doi-asserted-by":"crossref","first-page":"eaau4543","DOI":"10.1126\/scisignal.aau4543","volume":"12","author":"DS Harischandra","year":"2019","unstructured":"Harischandra DS et al (2019) Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of \u03b1-synuclein. Sci Signal 12:eaau4543","journal-title":"Sci Signal"},{"key":"4788_CR39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2017.00172","volume":"11","author":"M Delenclos","year":"2017","unstructured":"Delenclos M et al (2017) Investigation of endocytic pathways for the internalization of exosome-associated oligomeric alpha-synuclein. Front Neurosci 11:172","journal-title":"Front Neurosci"},{"key":"4788_CR40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10571-018-0622-5","volume":"38","author":"G Gustafsson","year":"2018","unstructured":"Gustafsson G et al (2018) Secretion and uptake of \u03b1-synuclein via extracellular vesicles in cultured cells. Cell Mol Neurobiol 38:1539\u20131550","journal-title":"Cell Mol Neurobiol"},{"key":"4788_CR41","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E et al (2010) Cell-produced \u03b1-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838\u20136851","journal-title":"J Neurosci"},{"key":"4788_CR42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M et al (2014) Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol 128:639\u2013650","journal-title":"Acta Neuropathol"},{"key":"4788_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"Y-T Sui","year":"2014","unstructured":"Sui Y-T et al (2014) Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier. Peptides 62:197\u2013202","journal-title":"Peptides"},{"key":"4788_CR44","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S et al (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 12:1012","journal-title":"Cells"},{"key":"4788_CR45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/biom12070957","volume":"12","author":"P Mavroeidi","year":"2022","unstructured":"Mavroeidi P et al (2022) Exosomes in alpha-synucleinopathies: propagators of pathology or potential candidates for nanotherapeutics? Biomolecules 12:957","journal-title":"Biomolecules"},{"key":"4788_CR46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12575-021-00158-4","volume":"23","author":"Z Payandeh","year":"2021","unstructured":"Payandeh Z et al (2021) The role of cell organelles in rheumatoid arthritis with focus on exosomes. Biol Proced Online 23:20","journal-title":"Biol Proced Online"},{"issue":"5","key":"4788_CR47","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M et al (2020) Microglial exosomes facilitate a-synuclein transmission in Parkinson\u2019s disease. Brain 143(5):1476\u20131497","journal-title":"Brain"},{"key":"4788_CR48","doi-asserted-by":"crossref","first-page":"eabn1298","DOI":"10.1126\/sciadv.abn1298","volume":"8","author":"I Choi","year":"2022","unstructured":"Choi I et al (2022) Regulation of \u03b1-synuclein homeostasis and inflammasome activation by microglial autophagy. Sci Adv 8:eabn1298","journal-title":"Sci Adv"},{"key":"4788_CR49","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3390\/ijms24032477","volume":"24","author":"JS Deyell","year":"2023","unstructured":"Deyell JS et al (2023) The interplay between \u03b1-synuclein and microglia in \u03b1-synucleinopathies. Int J Mol Sci 24:2477","journal-title":"Int J Mol Sci"},{"key":"4788_CR50","doi-asserted-by":"crossref","first-page":"1411104","DOI":"10.3389\/fnagi.2024.1411104","volume":"16","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yu H, Feng J (2024) Emerging role of microglia in inter-cellular transmission of \u03b1-synuclein in Parkinson\u2019s disease. Front Aging Neurosci 16:1411104","journal-title":"Front Aging Neurosci"},{"key":"4788_CR51","doi-asserted-by":"crossref","first-page":"107742","DOI":"10.1016\/j.jbc.2024.107742","volume":"300","author":"A Bayati","year":"2024","unstructured":"Bayati A, McPherson PS (2024) Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions. J Biol Chem 300:107742","journal-title":"J Biol Chem"},{"key":"4788_CR52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","volume":"2","author":"V Cullen","year":"2009","unstructured":"Cullen V et al (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2:5","journal-title":"Mol Brain"},{"key":"4788_CR53","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","volume":"112","author":"RP McGlinchey","year":"2015","unstructured":"McGlinchey RP, Lee JC (2015) Cysteine cathepsins are essential in lysosomal degradation of \u03b1-synuclein. Proc Natl Acad Sci 112:9322\u20139327","journal-title":"Proc Natl Acad Sci"},{"key":"4788_CR54","doi-asserted-by":"crossref","first-page":"805087","DOI":"10.3389\/fnmol.2022.805087","volume":"15","author":"D Sep\u00falveda","year":"2022","unstructured":"Sep\u00falveda D et al (2022) Contribution of autophagy-lysosomal pathway in the exosomal secretion of alpha-synuclein and its impact in the progression of Parkinson\u2019s disease. Front Mol Neurosci 15:805087","journal-title":"Front Mol Neurosci"},{"key":"4788_CR55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C et al (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8:359","journal-title":"Signal Transduct Target Ther"},{"key":"4788_CR56","doi-asserted-by":"crossref","first-page":"643254","DOI":"10.3389\/fphar.2021.643254","volume":"12","author":"JA Holbrook","year":"2021","unstructured":"Holbrook JA et al (2021) Neurodegenerative disease and the NLRP3 inflammasome. Front Pharmacol 12:643254","journal-title":"Front Pharmacol"},{"key":"4788_CR57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA et al (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10\u201320","journal-title":"Brain Res Bull"},{"key":"4788_CR58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/AN20120066","volume":"5","author":"V Sanchez-Guajardo","year":"2013","unstructured":"Sanchez-Guajardo V et al (2013) Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro 5:113\u2013139","journal-title":"ASN Neuro"},{"key":"4788_CR59","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY et al (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3:136","journal-title":"Ann Transl Med"},{"key":"4788_CR60","doi-asserted-by":"crossref","first-page":"113525","DOI":"10.1016\/j.expneurol.2020.113525","volume":"336","author":"X-L Si","year":"2021","unstructured":"Si X-L et al (2021) From inflammasome to Parkinson\u2019s disease: does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson\u2019s disease? Exp Neurol 336:113525","journal-title":"Exp Neurol"},{"key":"4788_CR61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267","journal-title":"Signal Transduct Target Ther"},{"key":"4788_CR62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbadis.2015.10.026","volume":"1862","author":"B Kaminska","year":"2016","unstructured":"Kaminska B, Mota M, Pizzi M (2016) Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation. Biochim Biophys Acta (BBA)-Mol Basis Dis 1862:339\u2013351","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"4788_CR63","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1096\/fj.11-197194","volume":"26","author":"SD Skaper","year":"2012","unstructured":"Skaper SD, Giusti P, Facci L (2012) Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 26:3103\u20133117","journal-title":"FASEB J"},{"key":"4788_CR64","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","volume":"290","author":"M Grey","year":"2015","unstructured":"Grey M et al (2015) Acceleration of \u03b1-synuclein aggregation by exosomes. J Biol Chem 290:2969\u20132982","journal-title":"J Biol Chem"},{"key":"4788_CR65","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbapap.2018.07.004","volume":"1866","author":"R Gaspar","year":"2018","unstructured":"Gaspar R et al (2018) Ganglioside lipids accelerate \u03b1-synuclein amyloid formation. Biochim Biophys Acta Proteins Proteom 1866:1062\u20131072","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"4788_CR66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms21030868","volume":"21","author":"E Chiricozzi","year":"2020","unstructured":"Chiricozzi E et al (2020) GM1 Ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration. Int J Mol Sci. 21:868","journal-title":"Int J Mol Sci."},{"key":"4788_CR67","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","volume":"46","author":"Z Martinez","year":"2007","unstructured":"Martinez Z et al (2007) GM1 specifically interacts with \u03b1-synuclein and inhibits fibrillation \u2020. Biochemistry 46:1868\u20131877","journal-title":"Biochemistry"},{"key":"4788_CR68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/biom12050655","volume":"12","author":"C Chavarr\u00eda","year":"2022","unstructured":"Chavarr\u00eda C, Ivagnes R, Souza JM (2022) Extracellular alpha-synuclein: mechanisms for glial cell internalization and activation. Biomolecules 12:655","journal-title":"Biomolecules"},{"key":"4788_CR69","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41374-019-0195-z","volume":"99","author":"RJ Karpowicz","year":"2019","unstructured":"Karpowicz RJ, Trojanowski JQ, Lee VMY (2019) Transmission of \u03b1-synuclein seeds in neurodegenerative disease: recent developments. Lab Invest 99:971\u2013981","journal-title":"Lab Invest"},{"key":"4788_CR70","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Benito M et al (2020) Modeling Parkinson\u2019s disease with the alpha-synuclein protein. Front Pharmacol 11. https:\/\/doi.org\/10.3389\/fphar.2020.00356","DOI":"10.3389\/fphar.2020.00356"},{"key":"4788_CR71","first-page":"217","volume":"1","author":"I Russo","year":"2012","unstructured":"Russo I, Bubacco L, Greggio E (2012) Exosomes-associated neurodegeneration and progression of Parkinson\u2019s disease. Am J Neurodegener Dis 1:217\u2013225","journal-title":"Am J Neurodegener Dis"},{"key":"4788_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-140491","volume":"5","author":"HE Allen Reish","year":"2015","unstructured":"Allen Reish HE, Standaert DG (2015) Role of \u03b1-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis 5:1\u201319","journal-title":"J Parkinsons Dis"},{"key":"4788_CR73","doi-asserted-by":"crossref","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4788_CR74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan micrornas. Cell 173:20\u201351","journal-title":"Cell"},{"key":"4788_CR75","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953","journal-title":"Science"},{"key":"4788_CR76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jnc.14724","volume":"150","author":"S Lu","year":"2019","unstructured":"Lu S et al (2019) Current status and potential role of circular RNAs in neurological disorders. J Neurochem 150:237\u2013248","journal-title":"J Neurochem"},{"key":"4788_CR77","doi-asserted-by":"crossref","first-page":"819836","DOI":"10.3389\/fnagi.2022.819836","volume":"14","author":"P Zhang","year":"2022","unstructured":"Zhang P et al (2022) Emerging potential of exosomal non-coding RNA in Parkinson\u2019s disease: a review. Front Aging Neurosci 14:819836","journal-title":"Front Aging Neurosci"},{"key":"4788_CR78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"H-X Chen","year":"2020","unstructured":"Chen H-X et al (2020) Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis 11:288","journal-title":"Cell Death Dis"},{"key":"4788_CR79","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13238-015-0168-y","volume":"6","author":"S Mao","year":"2015","unstructured":"Mao S et al (2015) Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2. Protein Cell 6:529\u2013540","journal-title":"Protein Cell"},{"key":"4788_CR80","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","volume":"23","author":"Q Li","year":"2021","unstructured":"Li Q et al (2021) Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease. Mol Ther Nucleic Acids 23:1334\u20131344","journal-title":"Mol Ther Nucleic Acids"},{"key":"4788_CR81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neuroscience.2020.08.004","volume":"446","author":"Y-Q Yan","year":"2020","unstructured":"Yan Y-Q et al (2020) NLRP3 Inflammasomes in Parkinson\u2019s disease and their regulation by Parkin. Neuroscience 446:323\u2013334","journal-title":"Neuroscience"},{"key":"4788_CR82","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/ijms20225649","volume":"20","author":"SY Goh","year":"2019","unstructured":"Goh SY et al (2019) Role of microRNAs in Parkinson\u2019s disease. Int J Mol Sci 20:5649","journal-title":"Int J Mol Sci"},{"key":"4788_CR83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnmol.2017.00328","volume":"10","author":"LK Shamsuzzama","year":"2017","unstructured":"Shamsuzzama LK, Nazir A (2017) Modulation of alpha-synuclein expression and associated effects by microRNA let-7 in transgenic C elegans. Front Mol Neurosci 10:328","journal-title":"Front Mol Neurosci"},{"key":"4788_CR84","doi-asserted-by":"crossref","first-page":"611904","DOI":"10.3389\/fnins.2020.611904","volume":"14","author":"MR Volkert","year":"2020","unstructured":"Volkert MR, Crowley DJ (2020) Preventing neurodegeneration by controlling oxidative stress: the role of OXR1. Front Neurosci 14:611904","journal-title":"Front Neurosci"},{"key":"4788_CR85","doi-asserted-by":"crossref","first-page":"146331","DOI":"10.1016\/j.brainres.2019.146331","volume":"1722","author":"Y Jiang","year":"2019","unstructured":"Jiang Y et al (2019b) Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson\u2019s disease. Brain Res 1722:146331","journal-title":"Brain Res"},{"key":"4788_CR86","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3390\/ijms22062951","volume":"22","author":"F Anastasi","year":"2021","unstructured":"Anastasi F et al (2021) Proteomics profiling of neuron-derived small extracellular vesicles from human plasma: enabling single-subject analysis. Int J Mol Sci 22:2951","journal-title":"Int J Mol Sci"},{"key":"4788_CR87","doi-asserted-by":"crossref","first-page":"101694","DOI":"10.1016\/j.pneurobio.2019.101694","volume":"183","author":"X Xia","year":"2019","unstructured":"Xia X et al (2019) Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents. Prog Neurobiol 183:101694","journal-title":"Prog Neurobiol"},{"key":"4788_CR88","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/brain\/awab122","volume":"144","author":"Y Xia","year":"2021","unstructured":"Xia Y et al (2021) Reactive microglia enhance the transmission of exosomal \u03b1-synuclein via toll-like receptor 2. Brain 144:2024\u20132037","journal-title":"Brain"},{"key":"4788_CR89","doi-asserted-by":"crossref","first-page":"136414","DOI":"10.1016\/j.neulet.2021.136414","volume":"771","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson\u2019s disease. Neurosci Lett 771:136414","journal-title":"Neurosci Lett"},{"key":"4788_CR90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2018.10.040","volume":"690","author":"J Vargas-Medrano","year":"2019","unstructured":"Vargas-Medrano J et al (2019) Up-regulation of protective neuronal MicroRNAs by FTY720 and novel FTY720-derivatives. Neurosci Lett 690:178\u2013180","journal-title":"Neurosci Lett"},{"key":"4788_CR91","first-page":"1","volume":"24","author":"W Wang","year":"2021","unstructured":"Wang W et al (2021b) circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK\/mTOR pathway in Parkinson\u2019s disease. Mol Med Rep 24:1\u201310","journal-title":"Mol Med Rep"},{"key":"4788_CR92","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2023.08.037","volume":"678","author":"G Lindner","year":"2023","unstructured":"Lindner G et al (2023) Protein-coding circular RNAs \u2013 mechanism, detection, and their role in cancer and neurodegenerative diseases. Biochem Biophys Res Commun 678:68\u201377","journal-title":"Biochem Biophys Res Commun"},{"key":"4788_CR93","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A et al (2015) Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell 58:870\u2013885","journal-title":"Mol Cell"},{"key":"4788_CR94","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2019.11.102","volume":"522","author":"Z Feng","year":"2020","unstructured":"Feng Z et al (2020) Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p\/CREB pathway in Parkinson\u2019s disease. Biochem Biophys Res Commun 522:388\u2013394","journal-title":"Biochem Biophys Res Commun"},{"key":"4788_CR95","doi-asserted-by":"crossref","first-page":"e11942","DOI":"10.15252\/emmm.201911942","volume":"12","author":"M Hanan","year":"2020","unstructured":"Hanan M et al (2020) A Parkinson\u2019s disease CircRNAs resource reveals a link between circ SLC 8A1 and oxidative stress. EMBO Mol Med 12:e11942","journal-title":"EMBO Mol Med"},{"key":"4788_CR96","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1007\/s12035-018-0903-5","volume":"55","author":"L Kumar","year":"2018","unstructured":"Kumar L et al (2018) Functional characterization of novel circular RNA molecule, circzip-2 and its synthesizing gene zip-2 in C. elegans model of Parkinson\u2019s disease. Mol Neurobiol 55:6914\u20136926","journal-title":"Mol Neurobiol"},{"issue":"3","key":"4788_CR97","doi-asserted-by":"crossref","first-page":"e14435","DOI":"10.1111\/cns.14435","volume":"30","author":"Q Wang","year":"2023","unstructured":"Wang Q et al (2023a) Transcriptome sequencing of circular RNA reveals the involvement of hsa-SCMH1_0001 in the pathogenesis of Parkinson\u2019s disease. CNS Neurosci Ther 30(3):e14435","journal-title":"CNS Neurosci Ther"},{"key":"4788_CR98","doi-asserted-by":"crossref","first-page":"e14435","DOI":"10.1111\/cns.14435","volume":"30","author":"Q Wang","year":"2024","unstructured":"Wang Q et al (2024) Transcriptome sequencing of circular RNA reveals the involvement of hsa-SCMH1_0001 in the pathogenesis of Parkinson\u2019s disease. CNS Neurosci Ther 30:e14435","journal-title":"CNS Neurosci Ther"},{"key":"4788_CR99","doi-asserted-by":"crossref","first-page":"9839","DOI":"10.3390\/ijms22189839","volume":"22","author":"G Fonseca Cabral","year":"2021","unstructured":"Fonseca Cabral G et al (2021) Nuclear and mitochondrial genome, epigenome and gut microbiome: emerging molecular biomarkers for Parkinson\u2019s disease. Int J Mol Sci 22:9839","journal-title":"Int J Mol Sci"},{"key":"4788_CR100","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","volume":"71","author":"B Guan","year":"2011","unstructured":"Guan B, Wang TL, Shih Ie M (2011) ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 71:6718\u20136727","journal-title":"Cancer Res"},{"key":"4788_CR101","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.18632\/aging.101466","volume":"10","author":"Q Sang","year":"2018","unstructured":"Sang Q et al (2018) CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson\u2019s disease by targeting miR-7. Aging (albany NY) 10:1281","journal-title":"Aging (albany NY)"},{"key":"4788_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-021-00820-6","volume":"37","author":"X Cao","year":"2022","unstructured":"Cao X et al (2022) Circular RNA circ_0070441 regulates MPP+-triggered neurotoxic effect in SH-SY5Y cells via miR-626\/IRS2 axis. Metab Brain Dis 37:1\u201312","journal-title":"Metab Brain Dis"},{"key":"4788_CR103","doi-asserted-by":"crossref","first-page":"e25888","DOI":"10.1097\/MD.0000000000025888","volume":"100","author":"F Kong","year":"2021","unstructured":"Kong F et al (2021) RNA-sequencing of peripheral blood circular RNAs in Parkinson disease. Medicine 100:e25888","journal-title":"Medicine"},{"key":"4788_CR104","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41419-022-04934-2","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q et al (2022) circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p\/\u03b1-syn pathway in Parkinson\u2019s disease. Cell Death Dis 13:477","journal-title":"Cell Death Dis"},{"key":"4788_CR105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/08941939.2020.1771639","volume":"34","author":"M Wang","year":"2021","unstructured":"Wang M et al (2021a) CircRNA 001372 reduces inflammation in propofol-induced neuroinflammation and neural apoptosis through PIK3CA\/Akt\/NF-\u03baB by miRNA-148b-3p. J Invest Surg 34:1167\u20131177","journal-title":"J Invest Surg"},{"key":"4788_CR106","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","volume":"53","author":"L Xu","year":"2016","unstructured":"Xu L, He D, Bai Y (2016) Microglia-mediated inflammation and neurodegenerative disease. Mol Neurobiol 53:6709\u20136715","journal-title":"Mol Neurobiol"},{"issue":"5","key":"4788_CR107","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M et al (2020) Microglial exosomes facilitate a-synuclein transmission in Parkinson\u2019s disease. Brain 143(5):1476\u20131497","journal-title":"Brain"},{"key":"4788_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-1-2","volume":"1","author":"NP Visanji","year":"2013","unstructured":"Visanji NP et al (2013) The prion hypothesis in Parkinson\u2019s disease: Braak to the future. Acta Neuropathol Commun 1:1\u201312","journal-title":"Acta Neuropathol Commun"},{"key":"4788_CR109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki G et al (2018) Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy 14:98\u2013119","journal-title":"Autophagy"},{"key":"4788_CR110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A et al (2016) Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain 139:481\u2013494","journal-title":"Brain"},{"key":"4788_CR111","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s12035-022-03179-6","volume":"60","author":"Y Jin","year":"2023","unstructured":"Jin Y et al (2023) Exosomes from inflamed macrophages promote the progression of Parkinson\u2019s disease by inducing neuroinflammation. Mol Neurobiol 60:1914\u20131928","journal-title":"Mol Neurobiol"},{"key":"4788_CR112","doi-asserted-by":"publisher","unstructured":"Kouli A, Torsney KM, Kuan W-L (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. Exon Publications 3\u201326. https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch1","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"4788_CR113","doi-asserted-by":"crossref","first-page":"105700","DOI":"10.1016\/j.nbd.2022.105700","volume":"168","author":"F Weiss","year":"2022","unstructured":"Weiss F et al (2022) Immune responses in the Parkinson\u2019s disease brain. Neurobiol Dis 168:105700","journal-title":"Neurobiol Dis"},{"key":"4788_CR114","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","volume":"522","author":"S Latif","year":"2021","unstructured":"Latif S et al (2021) Dopamine in Parkinson\u2019s disease. Clin Chim Acta 522:114\u2013126","journal-title":"Clin Chim Acta"},{"key":"4788_CR115","doi-asserted-by":"crossref","first-page":"736978","DOI":"10.3389\/fmed.2021.736978","volume":"8","author":"E Srinivasan","year":"2021","unstructured":"Srinivasan E et al (2021) Alpha-synuclein aggregation in Parkinson\u2019s disease. Front Med 8:736978","journal-title":"Front Med"},{"key":"4788_CR116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","volume":"111","author":"PM Carvey","year":"2009","unstructured":"Carvey PM, Hendey B, Monahan AJ (2009) The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J Neurochem 111:291\u2013314","journal-title":"J Neurochem"},{"key":"4788_CR117","doi-asserted-by":"crossref","first-page":"897022","DOI":"10.3389\/fimmu.2022.897022","volume":"13","author":"EE Wicks","year":"2022","unstructured":"Wicks EE et al (2022) The translational potential of microglia and monocyte-derived macrophages in ischemic stroke. Front Immunol 13:897022","journal-title":"Front Immunol"},{"key":"4788_CR118","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","volume":"19","author":"A DeMaio","year":"2022","unstructured":"DeMaio A et al (2022) The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation 19:251","journal-title":"J Neuroinflammation"},{"key":"4788_CR119","doi-asserted-by":"crossref","first-page":"7965433","DOI":"10.1155\/2022\/7965433","volume":"2022","author":"Z Zheng","year":"2022","unstructured":"Zheng Z et al (2022b) Mechanisms of autoimmune cell in DA neuron apoptosis of Parkinson\u2019s disease: recent advancement. Oxid Med Cell Longev 2022:7965433","journal-title":"Oxid Med Cell Longev"},{"key":"4788_CR120","doi-asserted-by":"crossref","first-page":"1103416","DOI":"10.3389\/fneur.2023.1103416","volume":"14","author":"J Qin","year":"2023","unstructured":"Qin J et al (2023) Microglia activation in central nervous system disorders: a review of recent mechanistic investigations and development efforts. Front Neurol 14:1103416","journal-title":"Front Neurol"},{"key":"4788_CR121","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG et al (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673","journal-title":"Nat Rev Immunol"},{"key":"4788_CR122","doi-asserted-by":"crossref","first-page":"281","DOI":"10.37349\/ent.2023.00052","volume":"3","author":"Z Khan","year":"2023","unstructured":"Khan Z, Jung YJ (2023) The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson\u2019s disease. Explor Neuroprotective Ther 3:281\u2013298","journal-title":"Explor Neuroprotective Ther"},{"key":"4788_CR123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.26421","volume":"92","author":"Y Huang","year":"2022","unstructured":"Huang Y et al (2022) Parkinson\u2019s disease derived exosomes aggravate neuropathology in SNCA* A53T mice. Ann Neurol 92:230\u2013245","journal-title":"Ann Neurol"},{"key":"4788_CR124","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2012.11.004","volume":"532","author":"B Mollenhauer","year":"2013","unstructured":"Mollenhauer B et al (2013) Total CSF \u03b1-synuclein is lower in de novo Parkinson patients than in healthy subjects. Neurosci Lett 532:44\u201348","journal-title":"Neurosci Lett"},{"key":"4788_CR125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B et al (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230\u2013240","journal-title":"Lancet Neurol"},{"key":"4788_CR126","doi-asserted-by":"crossref","first-page":"e2332","DOI":"10.1212\/WNL.0000000000011853","volume":"96","author":"Z Hong","year":"2021","unstructured":"Hong Z et al (2021) Development of a sensitive diagnostic assay for Parkinson disease quantifying \u03b1-synuclein\u2013containing extracellular vesicles. Neurology 96:e2332\u2013e2345","journal-title":"Neurology"},{"key":"4788_CR127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2019.01.005","volume":"175","author":"M Shi","year":"2019","unstructured":"Shi M et al (2019) New windows into the brain: central nervous system-derived extracellular vesicles in blood. Prog Neurobiol 175:96\u2013106","journal-title":"Prog Neurobiol"},{"key":"4788_CR128","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","volume":"12","author":"AG Thompson","year":"2016","unstructured":"Thompson AG et al (2016) Extracellular vesicles in neurodegenerative disease\u2014pathogenesis to biomarkers. Nat Rev Neurol 12:346\u2013357","journal-title":"Nat Rev Neurol"},{"key":"4788_CR129","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3390\/diagnostics13132192","volume":"13","author":"D Anagnostou","year":"2023","unstructured":"Anagnostou D et al (2023) Assessment of aggregated and exosome-associated \u03b1-synuclein in brain tissue and cerebrospinal fluid using specific immunoassays. Diagnostics 13:2192","journal-title":"Diagnostics"},{"key":"4788_CR130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"186","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK (2019) \u03b1-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta (BBA)-Protein Proteomics 186:890\u2013908","journal-title":"Biochim Biophys Acta (BBA)-Protein Proteomics"},{"key":"4788_CR131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.22928","volume":"25","author":"R Duran","year":"2010","unstructured":"Duran R et al (2010) Plasma \u03b1-synuclein in patients with Parkinson\u2019s disease with and without treatment. Mov Disord 25:489\u2013493","journal-title":"Mov Disord"},{"key":"4788_CR132","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y et al (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043","journal-title":"Oncotarget"},{"key":"4788_CR133","doi-asserted-by":"crossref","first-page":"e0123162","DOI":"10.1371\/journal.pone.0123162","volume":"10","author":"R Ishii","year":"2015","unstructured":"Ishii R et al (2015) Decrease in plasma levels of \u03b1-synuclein is evident in patients with Parkinson\u2019s disease after elimination of heterophilic antibody interference. PLoS One 10:e0123162","journal-title":"PLoS One"},{"key":"4788_CR134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-00700-8","volume":"28","author":"M-C Kuo","year":"2021","unstructured":"Kuo M-C et al (2021) The role of noncoding RNAs in Parkinson\u2019s disease: biomarkers and associations with pathogenic pathways. J Biomed Sci 28:1\u201328","journal-title":"J Biomed Sci"},{"key":"4788_CR135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/acn3.729","volume":"6","author":"AS Ng","year":"2019","unstructured":"Ng AS et al (2019) Plasma alpha-synuclein detected by single molecule array is increased in PD. Ann Clin Transl Neurol 6:615\u2013619","journal-title":"Ann Clin Transl Neurol"},{"key":"4788_CR136","first-page":"427","volume":"2022","author":"G Tong","year":"2022","unstructured":"Tong G et al (2022b) Diagnostic test to identify Parkinson\u2019s disease from the blood sera of Chinese population: a cross-sectional study. Parkinson\u2019s Dis 2022:427\u2013433","journal-title":"Parkinson\u2019s Dis"},{"key":"4788_CR137","doi-asserted-by":"crossref","first-page":"e17478","DOI":"10.1097\/MD.0000000000017478","volume":"98","author":"R Jiang","year":"2019","unstructured":"Jiang R et al (2019a) Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease. Medicine. 98:e17478","journal-title":"Medicine."},{"key":"4788_CR138","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3389\/fcell.2020.00787","volume":"8","author":"MI Oliveira da Silva","year":"2020","unstructured":"Oliveira da Silva MI, Liz MA (2020) Linking alpha-synuclein to the actin cytoskeleton: consequences to neuronal function. Front Cell Dev Biol 8:787","journal-title":"Front Cell Dev Biol"},{"key":"4788_CR139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2011.07.027","volume":"412","author":"H Welander","year":"2011","unstructured":"Welander H et al (2011) Gelsolin co-occurs with Lewy bodies in vivo and accelerates \u03b1-synuclein aggregation in vitro. Biochem Biophys Res Commun 412:32\u201338","journal-title":"Biochem Biophys Res Commun"},{"key":"4788_CR140","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/ijms20102373","volume":"20","author":"A Picca","year":"2019","unstructured":"Picca A et al (2019) Mitochondrial-derived vesicles as candidate biomarkers in Parkinson\u2019s disease: rationale, design and methods of the EXosomes in PArkiNson Disease (EXPAND) study. Int J Mol Sci 20:2373","journal-title":"Int J Mol Sci"},{"key":"4788_CR141","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/jcm9020504","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A et al (2020) Mitochondrial signatures in circulating extracellular vesicles of older adults with Parkinson\u2019s disease: results from the EXosomes in PArkiNson\u2019s Disease (EXPAND) study. J Clin Med 9:504","journal-title":"J Clin Med"},{"key":"4788_CR142","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.brainresbull.2012.05.013","volume":"88","author":"S-Y Sun","year":"2012","unstructured":"Sun S-Y, An C-N, Pu X-P (2012) DJ-1 protein protects dopaminergic neurons against 6-OHDA\/MG-132-induced neurotoxicity in rats. Brain Res Bull 88:609\u2013616","journal-title":"Brain Res Bull"},{"key":"4788_CR143","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","volume":"10","author":"Z-H Zhao","year":"2019","unstructured":"Zhao Z-H et al (2019) Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease. Front Aging Neurosci 10:438","journal-title":"Front Aging Neurosci"},{"key":"4788_CR144","doi-asserted-by":"crossref","first-page":"e1350","DOI":"10.1038\/cddis.2014.307","volume":"5","author":"L Zondler","year":"2014","unstructured":"Zondler L et al (2014) DJ-1 interactions with \u03b1-synuclein attenuate aggregation and cellular toxicity in models of Parkinson\u2019s disease. Cell Death Dis 5:e1350\u2013e1350","journal-title":"Cell Death Dis"},{"key":"4788_CR145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fncel.2018.00125","volume":"12","author":"S Cerri","year":"2018","unstructured":"Cerri S et al (2018) The exosomal\/total \u03b1-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients. Front Cell Neurosci 12:125","journal-title":"Front Cell Neurosci"},{"key":"4788_CR146","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2021.06.033","volume":"469","author":"H Zheng","year":"2021","unstructured":"Zheng H et al (2021) Investigation of \u03b1-synuclein species in plasma exosomes and the oligomeric and phosphorylated \u03b1-synuclein as potential peripheral biomarker of Parkinson\u2019s disease. Neuroscience 469:79\u201390","journal-title":"Neuroscience"},{"key":"4788_CR147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/1673-5374.264454","volume":"15","author":"C Agliardi","year":"2020","unstructured":"Agliardi C, Clerici M (2020) Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain. Neural Regen Res 15:55","journal-title":"Neural Regen Res"},{"key":"4788_CR148","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fnins.2017.00278","volume":"11","author":"M Mustapic","year":"2017","unstructured":"Mustapic M et al (2017) Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci 11:278","journal-title":"Front Neurosci"},{"key":"4788_CR149","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-023-02557-1","volume":"145","author":"S Dutta","year":"2023","unstructured":"Dutta S et al (2023) Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges. Acta Neuropathol 145:515\u2013540","journal-title":"Acta Neuropathol"},{"key":"4788_CR150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.11.021","volume":"61","author":"T Ohmichi","year":"2019","unstructured":"Ohmichi T et al (2019) Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson\u2019s and related diseases. Parkinsonism Relat Disord 61:82\u201387","journal-title":"Parkinsonism Relat Disord"},{"key":"4788_CR151","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S et al (2021) \u03b1-synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol 142:495\u2013511","journal-title":"Acta Neuropathol"},{"key":"4788_CR152","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","volume":"91","author":"C Jiang","year":"2020","unstructured":"Jiang C et al (2020) Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry 91:720\u2013729","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4788_CR153","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1111\/ene.15537","volume":"29","author":"YQ Yan","year":"2022","unstructured":"Yan YQ et al (2022) Different patterns of exosomal \u03b1-synuclein between Parkinson\u2019s disease and probable rapid eye movement sleep behavior disorder. Eur J Neurol 29:3590\u20133599","journal-title":"Eur J Neurol"},{"key":"4788_CR154","doi-asserted-by":"crossref","first-page":"577874","DOI":"10.3389\/fneur.2020.577874","volume":"11","author":"J Mao","year":"2020","unstructured":"Mao J et al (2020) Association between REM sleep behavior disorder and cognitive dysfunctions in Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. Front Neurol 11:577874","journal-title":"Front Neurol"},{"key":"4788_CR155","doi-asserted-by":"crossref","first-page":"105947","DOI":"10.1016\/j.nbd.2022.105947","volume":"176","author":"M Meloni","year":"2023","unstructured":"Meloni M et al (2023) Oligomeric \u03b1-synuclein and tau aggregates in NDEVs differentiate Parkinson\u2019s disease from atypical parkinsonisms. Neurobiol Dis 176:105947","journal-title":"Neurobiol Dis"},{"key":"4788_CR156","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/mds.28591","volume":"36","author":"C Jiang","year":"2021","unstructured":"Jiang C et al (2021) Validation of \u03b1-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of parkinsonian syndromes. Mov Disord 36:2663\u20132669","journal-title":"Mov Disord"},{"key":"4788_CR157","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M et al (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69:570\u2013580","journal-title":"Ann Neurol"},{"key":"4788_CR158","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","volume":"644","author":"X-Y Cao","year":"2017","unstructured":"Cao X-Y et al (2017) MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles. Neurosci Lett 644:94\u201399","journal-title":"Neurosci Lett"},{"key":"4788_CR159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ensci.2018.09.002","volume":"13","author":"E Caggiu","year":"2018","unstructured":"Caggiu E et al (2018) Differential expression of miRNA 155 and miRNA 146a in Parkinson\u2019s disease patients. Eneurologicalsci 13:1\u20134","journal-title":"Eneurologicalsci"},{"key":"4788_CR160","first-page":"5278","volume":"22","author":"Y Yao","year":"2018","unstructured":"Yao Y et al (2018) Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson\u2019s disease. Eur Rev Med Pharmacol Sci 22:5278\u20135283","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4788_CR161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00225-y","volume":"10","author":"S He","year":"2021","unstructured":"He S et al (2021) Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson\u2019s disease. Transl Neurodegener 10:1\u201312","journal-title":"Transl Neurodegener"},{"key":"4788_CR162","doi-asserted-by":"crossref","first-page":"1037903","DOI":"10.3389\/fncel.2022.1037903","volume":"16","author":"P Bhattacharyya","year":"2023","unstructured":"Bhattacharyya P, Biswas A, Biswas SC (2023) Brain-enriched miR-128: reduced in exosomes from Parkinson\u2019s patient plasma, improves synaptic integrity, and prevents 6-OHDA mediated neuronal apoptosis. Front Cell Neurosci 16:1037903","journal-title":"Front Cell Neurosci"},{"key":"4788_CR163","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainresbull.2020.02.003","volume":"157","author":"Y Fan","year":"2020","unstructured":"Fan Y et al (2020) LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease via ablating microRNA-125b-5p. Brain Res Bull 157:119\u2013127","journal-title":"Brain Res Bull"},{"key":"4788_CR164","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s13311-020-00842-5","volume":"17","author":"J Zou","year":"2020","unstructured":"Zou J et al (2020) Long noncoding RNA POU3F3 and \u03b1-synuclein in plasma L1CAM exosomes combined with \u03b2-glucocerebrosidase activity: potential predictors of Parkinson\u2019s disease. Neurotherapeutics 17:1104\u20131119","journal-title":"Neurotherapeutics"},{"key":"4788_CR165","doi-asserted-by":"crossref","first-page":"102430","DOI":"10.1016\/j.redox.2022.102430","volume":"56","author":"Q Cheng","year":"2022","unstructured":"Cheng Q et al (2022) CircSV2b participates in oxidative stress regulation through miR-5107-5p-Foxk1-Akt1 axis in Parkinson\u2019s disease. Redox Biol 56:102430","journal-title":"Redox Biol"},{"key":"4788_CR166","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1007\/s10072-021-05408-7","volume":"42","author":"E Taghizadeh","year":"2021","unstructured":"Taghizadeh E et al (2021) LncRNAs as putative biomarkers and therapeutic targets for Parkinson\u2019s disease. Neurol Sci 42:4007\u20134015","journal-title":"Neurol Sci"},{"key":"4788_CR167","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/cns.13277","volume":"26","author":"Q Wang","year":"2020","unstructured":"Wang Q et al (2020a) Integrated analysis of exosomal lncRNA and mRNA expression profiles reveals the involvement of lnc-MKRN2-42: 1 in the pathogenesis of Parkinson\u2019s disease. CNS Neurosci Ther 26:527\u2013537","journal-title":"CNS Neurosci Ther"},{"key":"4788_CR168","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.parkreldis.2019.09.008","volume":"67","author":"K Rani","year":"2019","unstructured":"Rani K et al (2019) Neuronal exosomes in saliva of Parkinson\u2019s disease patients: a pilot study. Parkinsonism Relat Disord 67:21\u201323","journal-title":"Parkinsonism Relat Disord"},{"key":"4788_CR169","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Z Cao","year":"2019","unstructured":"Cao Z et al (2019) \u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 696:114\u2013120","journal-title":"Neurosci Lett"},{"key":"4788_CR170","first-page":"1","volume":"2014","author":"DH Ho","year":"2014","unstructured":"Ho DH et al (2014b) Increased DJ-1 in urine exosome of Korean males with Parkinson\u2019s disease. BioMed Res Int 2014:1\u20138","journal-title":"BioMed Res Int"},{"key":"4788_CR171","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","volume":"45","author":"S Wang","year":"2019","unstructured":"Wang S et al (2019) Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease. EBioMedicine 45:351\u2013361","journal-title":"EBioMedicine"},{"key":"4788_CR172","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/WNL.0000000000002436","volume":"86","author":"KB Fraser","year":"2016","unstructured":"Fraser KB et al (2016) Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers. Neurology 86:994\u2013999","journal-title":"Neurology"},{"key":"4788_CR173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1241757","volume":"2018","author":"J Jang","year":"2018","unstructured":"Jang J et al (2018a) Oxidized DJ-1 levels in urine samples as a putative biomarker for Parkinson\u2019s disease. Parkinson\u2019s Dis 2018:1\u20139","journal-title":"Parkinson\u2019s Dis"},{"key":"4788_CR174","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fphar.2018.00802","volume":"9","author":"L Arms","year":"2018","unstructured":"Arms L et al (2018) Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles. Front Pharmacol 9:802","journal-title":"Front Pharmacol"},{"key":"4788_CR175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","volume":"7","author":"E Nance","year":"2022","unstructured":"Nance E et al (2022) Drug delivery to the central nervous system. Nat Rev Mater 7:314\u2013331","journal-title":"Nat Rev Mater"},{"key":"4788_CR176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-022-00298-5","volume":"16","author":"J Wang","year":"2022","unstructured":"Wang J et al (2022) Dendrimer-based drug delivery systems: history, challenges, and latest developments. J Biol Eng 16:1\u201312","journal-title":"J Biol Eng"},{"key":"4788_CR177","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G (2021) Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 16:748\u2013759","journal-title":"Nat Nanotechnol"},{"key":"4788_CR178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-022-03325-7","volume":"20","author":"A Amiri","year":"2022","unstructured":"Amiri A et al (2022) Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med 20:1\u201316","journal-title":"J Transl Med"},{"key":"4788_CR179","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ et al (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 207:18\u201330","journal-title":"J Control Release"},{"key":"4788_CR180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","volume":"287","author":"M Qu","year":"2018","unstructured":"Qu M et al (2018) Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson\u2019s disease. J Control Release 287:156\u2013166","journal-title":"J Control Release"},{"key":"4788_CR181","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"JM Cooper","year":"2014","unstructured":"Cooper JM et al (2014) Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29:1476\u20131485","journal-title":"Mov Disord"},{"key":"4788_CR182","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","volume":"27","author":"M Izco","year":"2019","unstructured":"Izco M et al (2019) Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology. Mol Ther 27:2111\u20132122","journal-title":"Mol Ther"},{"key":"4788_CR183","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","volume":"17","author":"X Ren","year":"2019","unstructured":"Ren X et al (2019) Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model. Mol Ther-Nucleic Acids 17:726\u2013740","journal-title":"Mol Ther-Nucleic Acids"},{"key":"4788_CR184","doi-asserted-by":"crossref","first-page":"eaba3967","DOI":"10.1126\/sciadv.aba3967","volume":"6","author":"L Liu","year":"2020","unstructured":"Liu L et al (2020) Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease. Sci Adv 6:eaba3967","journal-title":"Sci Adv"},{"key":"4788_CR185","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","volume":"23","author":"Q Li","year":"2021","unstructured":"Li Q et al (2021) Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease. Mol Ther-Nucleic Acids 23:1334\u20131344","journal-title":"Mol Ther-Nucleic Acids"},{"key":"4788_CR186","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acschemneuro.1c00076","volume":"12","author":"X Meng","year":"2021","unstructured":"Meng X et al (2021) MiR-30a-5p regulates GLT-1 function via a PKC\u03b1-mediated ubiquitin degradation pathway in a mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 12:1578\u20131592","journal-title":"ACS Chem Neurosci"},{"key":"4788_CR187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-020-00716-z","volume":"14","author":"C Zhu","year":"2021","unstructured":"Zhu C et al (2021) Pharmacological inhibition of nSMase2 reduces brain exosome release and \u03b1-synuclein pathology in a Parkinson\u2019s disease model. Mol Brain 14:1\u20138","journal-title":"Mol Brain"},{"issue":"2","key":"4788_CR188","doi-asserted-by":"crossref","first-page":"e14393","DOI":"10.1111\/cns.14393","volume":"30","author":"Z Yu","year":"2023","unstructured":"Yu Z et al (2023) GV-971 attenuates \u03b1-synuclein aggregation and related pathology. CNS Neurosci Ther 30(2):e14393","journal-title":"CNS Neurosci Ther"},{"key":"4788_CR189","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jcyt.2014.07.013","volume":"17","author":"A Jarmalavi\u010di\u016bt\u0117","year":"2015","unstructured":"Jarmalavi\u010di\u016bt\u0117 A et al (2015) Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine\u2013induced apoptosis. Cytotherapy 17:932\u2013939","journal-title":"Cytotherapy"},{"key":"4788_CR190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/sctm.18-0162","volume":"8","author":"K Narbute","year":"2019","unstructured":"Narbute K et al (2019) Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the substantia nigra and striatum of the 6-hydroxydopamine-treated rats. Stem Cells Transl Med 8:490\u2013499","journal-title":"Stem Cells Transl Med"},{"key":"4788_CR191","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s11064-020-02977-5","volume":"45","author":"N Shakespear","year":"2020","unstructured":"Shakespear N et al (2020) Astrocyte-derived exosomal microRNA miR-200a-3p prevents MPP+-induced apoptotic cell death through down-regulation of MKK4. Neurochem Res 45:1020\u20131033","journal-title":"Neurochem Res"},{"key":"4788_CR192","doi-asserted-by":"crossref","first-page":"2201203","DOI":"10.1002\/adhm.202201203","volume":"11","author":"L Leggio","year":"2022","unstructured":"Leggio L et al (2022) Small extracellular vesicles secreted by nigrostriatal astrocytes rescue cell death and preserve mitochondrial function in Parkinson\u2019s disease. Adv Healthcare Mater 11:2201203","journal-title":"Adv Healthcare Mater"},{"key":"4788_CR193","doi-asserted-by":"crossref","first-page":"105218","DOI":"10.1016\/j.nbd.2020.105218","volume":"148","author":"J Yang","year":"2021","unstructured":"Yang J et al (2021) Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 148:105218","journal-title":"Neurobiol Dis"},{"key":"4788_CR194","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-021-00775-x","volume":"28","author":"M-C Kuo","year":"2021","unstructured":"Kuo M-C et al (2021) The role of noncoding RNAs in Parkinson\u2019s disease: biomarkers and associations with pathogenic pathways. J Biomed Sci 28:78","journal-title":"J Biomed Sci"},{"key":"4788_CR195","first-page":"8683877","volume":"2022","author":"G Tong","year":"2022","unstructured":"Tong G et al (2022a) Diagnostic test to identify Parkinson\u2019s disease from the blood sera of Chinese population: a cross-sectional study. Parkinson\u2019s Disease 2022:8683877","journal-title":"Parkinson\u2019s Disease"},{"key":"4788_CR196","first-page":"704678","volume":"2014","author":"DH Ho","year":"2014","unstructured":"Ho DH et al (2014a) Increased DJ-1 in urine exosome of Korean males with Parkinson\u2019s disease. Biomed Res Int 2014:704678","journal-title":"Biomed Res Int"},{"key":"4788_CR197","first-page":"1241757","volume":"2018","author":"J Jang","year":"2018","unstructured":"Jang J et al (2018b) Oxidized DJ-1 levels in urine samples as a putative biomarker for Parkinson\u2019s disease. Parkinson\u2019s Dis 2018:1241757","journal-title":"Parkinson\u2019s Dis"},{"key":"4788_CR198","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10561-022-10008-6","volume":"24","author":"M Mobahat","year":"2023","unstructured":"Mobahat M et al (2023) Curcumin-loaded human endometrial stem cells derived exosomes as an effective carrier to suppress alpha-synuclein aggregates in 6OHDA-induced Parkinson\u2019s disease mouse model. Cell Tissue Banking 24:75\u201391","journal-title":"Cell Tissue Banking"},{"key":"4788_CR199","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12967-023-04461-4","volume":"21","author":"Y Geng","year":"2023","unstructured":"Geng Y et al (2023) FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson\u2019s disease via m6A-dependent regulation of ATM mRNA. J Transl Med 21:652","journal-title":"J Transl Med"},{"key":"4788_CR200","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12967-023-04638-x","volume":"21","author":"S He","year":"2023","unstructured":"He S et al (2023) miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson\u2019s disease model via regulation of Nox4\/ROS\/Nrf2 signaling. J Transl Med 21:747","journal-title":"J Transl Med"},{"key":"4788_CR201","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0006-291X(83)91776-X","volume":"113","author":"C Harding","year":"1983","unstructured":"Harding C, Stahl P (1983) Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing. Biochem Biophys Res Commun 113:650\u2013658","journal-title":"Biochem Biophys Res Commun"},{"key":"4788_CR202","doi-asserted-by":"crossref","first-page":"32945","DOI":"10.3402\/jev.v5.32945","volume":"5","author":"C Gardiner","year":"2016","unstructured":"Gardiner C et al (2016) Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracellular Vesicles 5:32945","journal-title":"J Extracellular Vesicles"},{"key":"4788_CR203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02402-z","volume":"22","author":"BM Hussen","year":"2022","unstructured":"Hussen BM et al (2022) Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy. Cancer Cell Int 22:1\u201323","journal-title":"Cancer Cell Int"},{"key":"4788_CR204","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/pharmaceutics15010298","volume":"15","author":"A Cano","year":"2023","unstructured":"Cano A et al (2023) Exosomes-based nanomedicine for neurodegenerative diseases: current insights and future challenges. Pharmaceutics 15:298","journal-title":"Pharmaceutics"},{"key":"4788_CR205","doi-asserted-by":"crossref","first-page":"eabc0467","DOI":"10.1126\/sciadv.abc0467","volume":"7","author":"Y Gu","year":"2021","unstructured":"Gu Y et al (2021) Acoustofluidic centrifuge for nanoparticle enrichment and separation. Sci Adv 7:eabc0467","journal-title":"Sci Adv"},{"key":"4788_CR206","doi-asserted-by":"crossref","first-page":"2001581","DOI":"10.1002\/advs.202001581","volume":"7","author":"YT Kang","year":"2020","unstructured":"Kang YT et al (2020) Dual-isolation and profiling of circulating tumor cells and cancer exosomes from blood samples with melanoma using immunoaffinity-based microfluidic interfaces. Adv Sci 7:2001581","journal-title":"Adv Sci"},{"key":"4788_CR207","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1039\/D1LC00333J","volume":"21","author":"HM Tay","year":"2021","unstructured":"Tay HM et al (2021) Direct isolation of circulating extracellular vesicles from blood for vascular risk profiling in type 2 diabetes mellitus. Lab Chip 21:2511\u20132523","journal-title":"Lab Chip"},{"key":"4788_CR208","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1039\/D0LC00677G","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y et al (2020c) Microfluidic Raman biochip detection of exosomes: a promising tool for prostate cancer diagnosis. Lab Chip 20:4632\u20134637","journal-title":"Lab Chip"},{"key":"4788_CR209","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3892\/ijmm.2016.2759","volume":"38","author":"MC Deregibus","year":"2016","unstructured":"Deregibus MC et al (2016) Charge-based precipitation of extracellular vesicles. Int J Mol Med 38:1359\u20131366","journal-title":"Int J Mol Med"},{"key":"4788_CR210","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1039\/C8SC04197K","volume":"10","author":"F Gao","year":"2019","unstructured":"Gao F et al (2019) A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO 2. Chem Sci 10:1579\u20131588","journal-title":"Chem Sci"},{"key":"4788_CR211","doi-asserted-by":"crossref","first-page":"121571","DOI":"10.1016\/j.talanta.2020.121571","volume":"221","author":"N Zhang","year":"2021","unstructured":"Zhang N, Sun N, Deng C (2021) Rapid isolation and proteome analysis of urinary exosome based on double interactions of Fe3O4@ TiO2-DNA aptamer. Talanta 221:121571","journal-title":"Talanta"},{"key":"4788_CR212","doi-asserted-by":"publisher","unstructured":"Comfort N et al (2021) Nanoparticle tracking analysis for the quantification and size determination of extracellular vesicles. JoVE (Journal of Visualized Experiments). e62447. https:\/\/doi.org\/10.3791\/62447","DOI":"10.3791\/62447"},{"key":"4788_CR213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1534\/genetics.118.300227","volume":"211","author":"S Dunst","year":"2019","unstructured":"Dunst S, Tomancak P (2019) Imaging flies by fluorescence microscopy: principles, technologies, and applications. Genetics 211:15\u201334","journal-title":"Genetics"},{"key":"4788_CR214","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","volume":"27","author":"S Salarpour","year":"2019","unstructured":"Salarpour S et al (2019) Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci 27:533\u2013539","journal-title":"DARU J Pharm Sci"},{"key":"4788_CR215","first-page":"61","volume":"76","author":"X-M Xi","year":"2021","unstructured":"Xi X-M, Xia S-J, Lu R (2021) Drug loading techniques for exosome-based drug delivery systems. Die Pharm-Int J Pharm Sci 76:61\u201367","journal-title":"Die Pharm-Int J Pharm Sci"},{"key":"4788_CR216","doi-asserted-by":"crossref","first-page":"1700611","DOI":"10.1002\/advs.201700611","volume":"5","author":"Y Lin","year":"2018","unstructured":"Lin Y et al (2018) Exosome\u2013liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs. Adv Sci 5:1700611","journal-title":"Adv Sci"},{"key":"4788_CR217","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA et al (2020) Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci 21:4407","journal-title":"Int J Mol Sci"},{"key":"4788_CR218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-018-0211-z","volume":"20","author":"KI Mentkowski","year":"2018","unstructured":"Mentkowski KI et al (2018) Therapeutic potential of engineered extracellular vesicles. AAPS J 20:1\u201317","journal-title":"AAPS J"},{"key":"4788_CR219","doi-asserted-by":"crossref","first-page":"993940","DOI":"10.3389\/fneur.2022.993940","volume":"13","author":"H Zheng","year":"2022","unstructured":"Zheng H et al (2022a) Increased PRR14 and VCAM-1 level in serum of patients with Parkinson\u2019s disease. Front Neurol 13:993940","journal-title":"Front Neurol"},{"key":"4788_CR220","doi-asserted-by":"crossref","first-page":"17523","DOI":"10.1038\/s41598-018-35976-2","volume":"8","author":"Y Ando","year":"2018","unstructured":"Ando Y et al (2018) Brain-specific ultrastructure of capillary endothelial glycocalyx and its possible contribution for blood brain barrier. Sci Rep 8:17523","journal-title":"Sci Rep"},{"key":"4788_CR221","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345","journal-title":"Nat Biotechnol"},{"key":"4788_CR222","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","volume":"9","author":"M Khongkow","year":"2019","unstructured":"Khongkow M et al (2019) Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration. Sci Rep 9:8278","journal-title":"Sci Rep"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04788-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:53:43Z","timestamp":1751367223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04788-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":222,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4788"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04788-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no involvement of humans or animals in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}